हिंदी में पढ़ें

Novartis

Novartis aims for 5% annual sales growth through 2027

Novartis aims for 5% annual sales growth through 2027

Tue, Nov 28, 2023

Novartis said it was targeting annual sales growth of 5 per cent per year until 2027 and a core operating income margin of about 40 per cent by 2027, driven by innovative drugs on the market, after it severed ownership ties to its generic-drugs business.

French drugmaker Sanofi to appoint Novartis' Paul Hudson as next CEO

French drugmaker Sanofi to appoint Novartis' Paul Hudson as next CEO

Fri, Jun 07, 2019

Sanofi is poised to appoint Paul Hudson, a top executive with Switzerland`s Novartis, to become the French drugmaker`s next CEO from September 1.

Top Novartis lawyer exits over Trump attorney deal error

Top Novartis lawyer exits over Trump attorney deal error

Wed, May 16, 2018

Novartis` top lawyer Felix Ehrat is leaving the Swiss drugmaker, saying a $1.2 million contract he co-signed with U.S. President Donald Trump`s personal attorney was a mistake. The contract with Michael Cohen`s Essential Consultants, the same firm used to pay porn star Stormy Daniels, has distracted Novartis`s efforts to improve its image.

TRENDING NOW

Novartis says ended contract with firm linked to Trump lawyer

Novartis says ended contract with firm linked to Trump lawyer

Wed, May 09, 2018

It was responding to remarks by an attorney for porn star Stormy Daniels that Novartis was among companies that made payments to Cohen`s Essential Consultants outfit in late 2017 and early 2018.

Donald Trump tax cuts could mean more Novartis investment in US

Donald Trump tax cuts could mean more Novartis investment in US

Wed, Jan 18, 2017

Donald Trump`s plans to cut US corporate tax rates could trigger increased investment in the United States (US) by Novartis, its chief executive told Reuters, despite the president-elect`s recent harsh words on drug prices.

Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%

Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%

Thu, Dec 22, 2016

"Odomzo gives us an opportunity to meaningfully expand our already established branded dermatology business and support our expansion into branded oncology with a launched brand," Kirti Ganorkar, Global Head Business Development at Sun Pharma, said.

Breaking the mould: GSK picks Big Pharma's first female CEO

Breaking the mould: GSK picks Big Pharma's first female CEO

Tue, Sep 20, 2016

Emma Walmsley, GlaxoSmithKline's (GSK) incoming CEO, breaks the mould as the first woman to lead a top global drugmaker and stands out among Big Pharma bosses as a consumer brands guru rather than a prescription medicines expert.

Novartis prepares to sell Rs 91,800 crore stake in rival Roche

Novartis prepares to sell Rs 91,800 crore stake in rival Roche

Mon, Apr 25, 2016

The company has already hired banks to support the selling process of the sale of the 33% in Roche

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x